Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00087581 · ClinicalTrials.gov registry record · Phase 4

Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation

A Phase 4 study of Kidney Transplantation, sponsored by Hoffmann-La Roche.

Completed
Registry status
Phase 4
Development phase
720
Enrollment target
20
Study locations

NCT00087581 is a Phase 4 study of Kidney Transplantation that has completed, run by Hoffmann-La Roche. The registered enrollment target is 720 participants, above the 246-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (193% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00087581, a Phase 4 study of Kidney Transplantation, has completed, sponsored by Hoffmann-La Roche.

COMPLETED
Registry status
Phase 4
Development phase
720 participants
Enrollment target
20
Study locations

Study Summary

This three-arm study will evaluate the efficacy and safety of various dosing regimens of MMF combined with various dosing regimens of calcineurin inhibitor (CNI), either cyclosporine or tacrolimus, in participants who have undergone kidney transplantation. Participants will be randomized to one of three dosing regimens to receive concentration-controlled MMF with reduced CNI, concentration-controlled MMF with standard CNI, or fixed-dose MMF with standard CNI. Participants will be followed for 20-24 months after randomization.

Conditions Studied

Kidney Transplantation

Interventions

  • DRUG Tacrolimus
  • DRUG Cyclosporine
  • DRUG Mycophenolate mofetil

Study Locations (20)

Florida

  • - Gainesville
  • - Jacksonville
  • - Miami
  • - Orlando
  • - Tampa

California

  • - Bakersfield
  • - Los Angeles
  • - Los Angeles
  • - San Francisco

Louisiana

  • - New Orleans
  • - Shreveport

Alabama

  • - Birmingham

Arkansas

  • - Little Rock

Colorado

  • - Denver

Georgia

  • - Augusta

Illinois

  • - Chicago

Trial Details

FieldValue
Enrollment Target 720 participants
Start Date 2004-06
Est. Completion 2007-09
Phase Phase 4

Sponsor

Hoffmann-La Roche

909 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00087581

The ClinicalTrials.gov registry entry for NCT00087581 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 246-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (193% higher). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Transplantation appearing as the primary indexed condition, and to 3 interventions - of which Tacrolimus is the first listed.

NCT00087581 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, California, Louisiana.

Frequently Asked Questions

What is clinical trial NCT00087581 about?

NCT00087581 is a clinical study titled "Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation". This three-arm study will evaluate the efficacy and safety of various dosing regimens of MMF combined with various dosing regimens of calcineurin inhibitor (CNI), either cyclosporine or tacrolimus, in participants who have undergone kidney transplantation. Participants will be randomized to one of t...

What is the current status of trial NCT00087581?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 720 participants. The study started on 2004-06. Estimated completion is 2007-09.

What conditions does trial NCT00087581 study?

This clinical trial studies the following conditions: Kidney Transplantation.

What interventions are being tested in trial NCT00087581?

The interventions under investigation include: Tacrolimus (DRUG), Cyclosporine (DRUG), Mycophenolate mofetil (DRUG).

Who is sponsoring clinical trial NCT00087581?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00087581 being conducted?

This trial has 20 study locations across Alabama, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Transplantation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.